Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2008;52:137-142
Published online before print May 26, 2008, doi: 10.1161/HYPERTENSIONAHA.108.111435
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
52/1/137    most recent
HYPERTENSIONAHA.108.111435v2
HYPERTENSIONAHA.108.111435v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Zhao, D.
Right arrow Articles by Navar, L. G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, D.
Right arrow Articles by Navar, L. G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*SODIUM
Related Collections
Right arrow Other hypertension

(Hypertension. 2008;52:137.)
© 2008 American Heart Association, Inc.


Original Articles

Acute Angiotensin II Infusions Elicit Pressure Natriuresis in Mice and Reduce Distal Fractional Sodium Reabsorption

Di Zhao; L. Gabriel Navar

From the Department of Physiology and Hypertension and Renal Center of Excellence, Tulane University School of Medicine, New Orleans, La.

Correspondence to L. Gabriel Navar, Department of Physiology SL-39, Tulane University Health Sciences Center, 1430 Tulane Ave, New Orleans, LA 70112. E-mail navar{at}tulane.edu

Acute angiotensin II (Ang II) infusions into mice increase arterial pressure (AP) and elicit pressure natriuresis. We used this model of pressure natriuresis to delineate the distal nephron responses to AP-mediated increases in distal sodium delivery. In the first group, we measured changes in urinary sodium excretion (UNaV) in male C57/BL6 anesthetized mice (n=9) before and during acute Ang II infusions (5 ng/g of body weight per minute). Acute Ang II infusions increased AP (98±3 to 126±5 mm Hg; P<0.001), urine flow (2.7±0.5 to 6.0±0.8 µL/min; P<0.01), and UNaV (0.6±0.2 to 1.3±0.2 µEq/min; P<0.05). There were significant relationships between UNaV and urine flow (y=0.207x+0.030; P<0.0001) and between UNaV and AP (y=0.027x–2.100). In a separate series, distal sodium delivery and fractional reabsorption of distal sodium delivery were determined in control (n=12) and Ang II–infused mice (n=8) by comparing UNaV before and after blockade of the 2 major distal nephron sodium transporters with amiloride (5 mg/kg of body weight) plus bendroflumethiazide (12 mg/kg of body weight). A positive relationship was found between UNaV (y=0.015x–1.100; P<0.0001) or distal sodium delivery (y=0.027x–0.900; P<0.0001) and AP. An inverse relationship was found between fractional reabsorption of distal sodium delivery and AP (y=–0.511x+128.300; P<0.01). These data indicate that Ang II–mediated pressure natriuresis involves an increase in distal sodium delivery combined with a reduced distal nephron fractional sodium reabsorption, suggesting that increased AP prevents the distal nephron transport mechanisms from accommodating the increased distal delivery.


Key Words: Ang II • arterial pressure • renal sodium reabsorption • distal nephron segments • amiloride • bendroflumethiazide • fractional distal sodium reabsorption